{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:39:25Z","timestamp":1792510765883,"version":"4.5.0"},"reference-count":40,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.m2026.0140","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:49:10Z","timestamp":1792507750000},"source":"Crossref","is-referenced-by-count":0,"title":["Polygenic risk scores: Towards clinical application"],"prefix":"10.3238","author":[{"given":"Johannes","family":"Schumacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Maj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus Maria","family":"N\u00f6then","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2026,10,30]]},"reference":[{"key":"10.3238\/arztebl.m2026.0140_ref1","doi-asserted-by":"crossref","unstructured":"McCarthy MI, Abecasis GR, Cardon LR, et al.: Genome-wide association studies for complex traits: Consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356&#8211;69.","DOI":"10.1038\/nrg2344"},{"key":"10.3238\/arztebl.m2026.0140_ref2","doi-asserted-by":"crossref","unstructured":"Visscher PM, Wray NR, Zhang Q, et al.: 10 Years of GWAS discovery: Biology, function, and translation. Am J Hum Genet 2017; 101: 5&#8211;22.","DOI":"10.1016\/j.ajhg.2017.06.005"},{"key":"10.3238\/arztebl.m2026.0140_ref3","doi-asserted-by":"crossref","unstructured":"Cerezo M, Sollis E, Ji Y, et al.: The NHGRI-EBI GWAS catalog: Standards for reusability, sustainability and diversity. Nucleic Acids Res 2025; 53: D998&#8211;D1005.","DOI":"10.1093\/nar\/gkae1070"},{"key":"10.3238\/arztebl.m2026.0140_ref4","doi-asserted-by":"crossref","unstructured":"Lewis CM, Vassos E: Polygenic risk scores: From research tools to clinical instruments. Genome Med 2020; 12: 44.","DOI":"10.1186\/s13073-020-00742-5"},{"key":"10.3238\/arztebl.m2026.0140_ref5","doi-asserted-by":"crossref","unstructured":"Xiang R, Kelemen M, Xu Y, et al.: Recent advances in polygenic scores: Translation, equitability, methods and FAIR tools. Genome Med 2024; 16: 33.","DOI":"10.1186\/s13073-024-01304-9"},{"key":"10.3238\/arztebl.m2026.0140_ref6","doi-asserted-by":"crossref","unstructured":"Zdravkovic S, Wienke A, Pedersen NL, Marenberg ME, Yashin AI, De Faire U: Heritability of death from coronary heart disease: A 36-year follow-up of 20 966 Swedish twins. J Intern Med 2002; 252: 247&#8211;54.","DOI":"10.1046\/j.1365-2796.2002.01029.x"},{"key":"10.3238\/arztebl.m2026.0140_ref7","doi-asserted-by":"crossref","unstructured":"Nikpay M, Stewart AFR, McPherson R: Partitioning the heritability of coronary artery disease highlights the importance of immune-mediated processes and epigenetic sites associated with transcriptional activity. Cardiovasc Res 2017; 113: 973&#8211;83.","DOI":"10.1093\/cvr\/cvx019"},{"key":"10.3238\/arztebl.m2026.0140_ref8","doi-asserted-by":"crossref","unstructured":"Lambert SA, Wingfield B, Gibson JT, et al.: Enhancing the polygenic score catalog with tools for score calculation and ancestry normalization. Nat Genet 2024; 56: 1989&#8211;94.","DOI":"10.1038\/s41588-024-01937-x"},{"key":"10.3238\/arztebl.m2026.0140_ref9","unstructured":"Caliebe A, Heinzel S, Schmidtke J, Krawczak M: Medizinreport: Genorakel polygene Risikoscores: M\u00f6glichkeiten und Grenzen. Deutsches \u00c4rzteblatt 2021; 8: A&#8211;410&#8211;6."},{"key":"10.3238\/arztebl.m2026.0140_ref10","doi-asserted-by":"crossref","unstructured":"Hollitt GL, Hassall MM, Siggs OM, Craig JE, Souzeau E: Development and evaluation of patient-centred polygenic risk score reports for glaucoma screening. BMC Med Genomics 2025; 18: 21.","DOI":"10.1186\/s12920-024-02079-z"},{"key":"10.3238\/arztebl.m2026.0140_ref11","doi-asserted-by":"crossref","unstructured":"Gallagher CS, Ginsburg GS, Musick A: Biobanking with genetics shapes precision medicine and global health. Nat Rev Genet 2025; 26: 191&#8211;202.","DOI":"10.1038\/s41576-024-00794-y"},{"key":"10.3238\/arztebl.m2026.0140_ref12","doi-asserted-by":"crossref","unstructured":"Marston NA, Pirruccello JP, Melloni GEM, et al.: Predictive utility of a coronary artery disease polygenic risk score in primary prevention. JAMA Cardiol 2023; 8: 130&#8211;7.","DOI":"10.1001\/jamacardio.2022.4466"},{"key":"10.3238\/arztebl.m2026.0140_ref13","doi-asserted-by":"crossref","unstructured":"Goff DC Jr., Lloyd-Jones DM, Bennett G, et al.: 2013 ACC\/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2935&#8211;59.","DOI":"10.1161\/01.cir.0000437741.48606.98"},{"key":"10.3238\/arztebl.m2026.0140_ref14","doi-asserted-by":"crossref","unstructured":"Haller PM, Melloni GEM, Berg DD, et al.: A polygenic risk score to predict incident heart failure across the spectrum of cardiovascular risk. J Am Coll Cardiol 2025; 86: 860&#8211;73.","DOI":"10.1016\/j.jacc.2025.06.050"},{"key":"10.3238\/arztebl.m2026.0140_ref15","doi-asserted-by":"crossref","unstructured":"Petitjean C, Wilcox N, Ficorella L, et al.: Evaluating the performance of the breast and ovarian analysis of disease incidence algorithm model in predicting 10-year breast cancer risks in UK biobank. J Natl Cancer Inst 2025; 117: 948&#8211;58.","DOI":"10.1093\/jnci\/djae335"},{"key":"10.3238\/arztebl.m2026.0140_ref16","unstructured":"No authors listed: Familial breast cancer: Classification, care and managing breast cancer and related risks in people with a family history of breast cancer. London: National Institute for Health and Care Excellence (NICE); 2023 PMID: 31940157."},{"key":"10.3238\/arztebl.m2026.0140_ref17","doi-asserted-by":"crossref","unstructured":"Fergus KB, Heise RS, Madlensky L, et al.: Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: A national randomized personalized screening trial. Genome Med 2025; 17: 97.","DOI":"10.1186\/s13073-025-01524-7"},{"key":"10.3238\/arztebl.m2026.0140_ref18","unstructured":"McHugh JK, Bancroft EK, Saunders E, et al.: Assessment of a polygenic risk score in screening for prostate cancer. N Engl J Med 2025; 392: 1406&#8211;17."},{"key":"10.3238\/arztebl.m2026.0140_ref19","unstructured":"Networt NNCC. Prostate Cancer. 2026. https:\/\/jnccn.org\/view\/journals\/jnccn\/23\/11\/article-p469.xml (last accessed on 20 July 2026)."},{"key":"10.3238\/arztebl.m2026.0140_ref20","unstructured":"Guidelines. E. EAU Guidelines. Edn. presented at the EAU Annual Congress Madrid 2025. ISBN 978&#8211;94&#8211;92671&#8211;29&#8211;5. https:\/\/uroweb.org\/guidelines. http:\/\/uroweb.org\/guidelines\/compilations-of-all-guidelines\/ (alst accessed on 20 July 2026)."},{"key":"10.3238\/arztebl.m2026.0140_ref21","doi-asserted-by":"crossref","unstructured":"Gallagher S, Hughes E, Wagner S, et al.: Association of a polygenic risk score with breast cancer among women carriers of high- and moderate-risk breast cancer genes. JAMA Netw Open 2020; 3: e208501.","DOI":"10.1001\/jamanetworkopen.2020.8501"},{"key":"10.3238\/arztebl.m2026.0140_ref22","doi-asserted-by":"crossref","unstructured":"Fahed AC, Wang M, Homburger JR, et al.: Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions. Nat Commun 2020; 11: 3635.","DOI":"10.1038\/s41467-020-17374-3"},{"key":"10.3238\/arztebl.m2026.0140_ref23","doi-asserted-by":"crossref","unstructured":"Mega JL, Stitziel NO, Smith JG, et al.: Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: An analysis of primary and secondary prevention trials. Lancet 2015; 385: 2264&#8211;71.","DOI":"10.1016\/S0140-6736(14)61730-X"},{"key":"10.3238\/arztebl.m2026.0140_ref24","doi-asserted-by":"crossref","unstructured":"Natarajan P, Young R, Stitziel NO, et al.: Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation 2017; 135: 2091&#8211;101.","DOI":"10.1161\/CIRCULATIONAHA.116.024436"},{"key":"10.3238\/arztebl.m2026.0140_ref25","doi-asserted-by":"crossref","unstructured":"Marston NA, Kamanu FK, Nordio F, et al.: Predicting benefit from evolocumab therapy in patients with atherosclerotic disease using a genetic risk score: Results from the FOURIER trial. Circulation 2020; 141: 616&#8211;23.","DOI":"10.1161\/CIRCULATIONAHA.119.043805"},{"key":"10.3238\/arztebl.m2026.0140_ref26","doi-asserted-by":"crossref","unstructured":"Damask A, Steg PG, Schwartz GG, et al.: Patients with high genome-wide polygenic risk scores for coronary artery disease may receive greater clinical benefit from alirocumab treatment in the ODYSSEY OUTCOMES Trial. Circulation 2020; 141: 624&#8211;36.","DOI":"10.1161\/CIRCULATIONAHA.119.044434"},{"key":"10.3238\/arztebl.m2026.0140_ref27","doi-asserted-by":"crossref","unstructured":"Singh S, Stocco G, Theken KN, et al.: Pharmacogenomics polygenic risk score: Ready or not for prime time? Clin Transl Sci 2024; 17: e13893.","DOI":"10.1111\/cts.13893"},{"key":"10.3238\/arztebl.m2026.0140_ref28","doi-asserted-by":"crossref","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ: Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet 2019; 51: 584&#8211;91.","DOI":"10.1038\/s41588-019-0379-x"},{"key":"10.3238\/arztebl.m2026.0140_ref29","unstructured":"Verma A, Huffman JE, Rodriguez A, et al.: Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program. Science 2024; 385: eadj1182."},{"key":"10.3238\/arztebl.m2026.0140_ref30","doi-asserted-by":"crossref","unstructured":"All of Us Research Program Investigators, Denny JC, Rutter JL, et al.: The &#8222;All of Us&#8220; Research Program. N Engl J Med 2019; 381: 668&#8211;76.","DOI":"10.1056\/NEJMsr1809937"},{"key":"10.3238\/arztebl.m2026.0140_ref31","doi-asserted-by":"crossref","unstructured":"Chen Z, Chen J, Collins R, et al.: China kadoorie biobank of 0.5 million people: Survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol 2011; 40: 1652&#8211;66.","DOI":"10.1093\/ije\/dyr120"},{"key":"10.3238\/arztebl.m2026.0140_ref32","doi-asserted-by":"crossref","unstructured":"Nagai A, Hirata M, Kamatani Y, et al.: Overview of the BioBank Japan Project: Study design and profile. J Epidemiol 2017; 27: S2&#8211;S8.","DOI":"10.1016\/j.je.2016.12.005"},{"key":"10.3238\/arztebl.m2026.0140_ref33","doi-asserted-by":"crossref","unstructured":"Kachuri L, Chatterjee N, Hirbo J, et al.: Principles and methods for transferring polygenic risk scores across global populations. Nat Rev Genet 2024; 25: 8&#8211;25.","DOI":"10.1038\/s41576-023-00637-2"},{"key":"10.3238\/arztebl.m2026.0140_ref34","doi-asserted-by":"crossref","unstructured":"Wand H, Lambert SA, Tamburro C, et al.: Improving reporting standards for polygenic scores in risk prediction studies. Nature 2021; 591: 211&#8211;9.","DOI":"10.1038\/s41586-021-03243-6"},{"key":"10.3238\/arztebl.m2026.0140_ref35","doi-asserted-by":"crossref","unstructured":"Fuat A, Adlen E, Monane M, et al.: A polygenic risk score added to a QRISK\u00ae2 cardiovascular disease risk calculator demonstrated robust clinical acceptance and clinical utility in the primary care setting. Eur J Prev Cardiol 2024; 31: 716&#8211;22.","DOI":"10.1093\/eurjpc\/zwae004"},{"key":"10.3238\/arztebl.m2026.0140_ref36","doi-asserted-by":"crossref","unstructured":"Linder JE, Allworth A, Bland HT, et al.: Returning integrated genomic risk and clinical recommendations: The eMERGE study. Genet Med 2023; 25: 100006.","DOI":"10.1016\/j.gim.2023.100006"},{"key":"10.3238\/arztebl.m2026.0140_ref37","doi-asserted-by":"crossref","unstructured":"Harris L, McDonagh EM, Zhang X, et al.: Genome-wide association testing beyond SNPs. Nat Rev Genet 2025; 26: 156&#8211;70.","DOI":"10.1038\/s41576-024-00778-y"},{"key":"10.3238\/arztebl.m2026.0140_ref38","unstructured":"Widen E, Junna N, Ruotsalainen S, et al.: How communicating polygenic and clinical risk for atherosclerotic cardiovascular disease impacts health behavior: An observational follow-up study. Circ Genom Precis Med 2022; 15: e003459."},{"key":"10.3238\/arztebl.m2026.0140_ref39","doi-asserted-by":"crossref","unstructured":"Johnston J, Matthews LJ: Polygenic embryo testing: Understated ethics, unclear utility. Nat Med 2022; 28: 446&#8211;8.","DOI":"10.1038\/s41591-022-01743-0"},{"key":"10.3238\/arztebl.m2026.0140_ref40","doi-asserted-by":"crossref","unstructured":"Capalbo A, de Wert G, Mertes H, et al.: Screening embryos for polygenic disease risk: A review of epidemiological, clinical, and ethical considerations. Hum Reprod Update 2024; 30: 529&#8211;57.","DOI":"10.1093\/humupd\/dmae012"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2026.0140","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:49:42Z","timestamp":1792507782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.m2026.0140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,30]]},"references-count":40,"URL":"https:\/\/doi.org\/10.3238\/arztebl.m2026.0140","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,30]]}}}